FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Sees Large Drop in Short Interest

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) saw a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 3,417 shares, a drop of 89.0% from the August 15th total of 30,976 shares. Based on an average daily volume of 7,563 shares, the short-interest ratio is currently 0.5 days. Currently, 0.0% of the shares of the company are short sold.

FT Vest U.S. Equity Deep Buffer ETF – October Price Performance

Shares of BATS:DOCT traded down $0.09 on Thursday, reaching $47.62. The company’s stock had a trading volume of 4,983 shares, compared to its average volume of 11,033. The stock’s 50-day moving average is $47.24 and its two-hundred day moving average is $45.96. FT Vest U.S. Equity Deep Buffer ETF – October has a 52-week low of $42.76 and a 52-week high of $48.42. The stock has a market capitalization of $391.91 million, a P/E ratio of 24.90 and a beta of 0.37.

Hedge Funds Weigh In On FT Vest U.S. Equity Deep Buffer ETF – October

A hedge fund recently raised its position in FT Vest U.S. Equity Deep Buffer ETF – October stock. Winnow Wealth LLC raised its stake in shares of FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) by 4,725.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 121,993 shares of the company’s stock after acquiring an additional 119,465 shares during the period. FT Vest U.S. Equity Deep Buffer ETF – October makes up 4.1% of Winnow Wealth LLC’s investment portfolio, making the stock its 5th biggest holding. Winnow Wealth LLC owned 1.48% of FT Vest U.S. Equity Deep Buffer ETF – October worth $5,490,000 as of its most recent filing with the Securities & Exchange Commission.

About FT Vest U.S. Equity Deep Buffer ETF – October

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.